| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Abnova (Taiwan) Corporation (TW: 4133)
4133 Technical Analysis
4
| As on 27th Jan 2026 4133 STOCK Price closed @ 26.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 27.90 & Strong Sell for SHORT-TERM with Stoploss of 29.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4133STOCK Price
| Open | 23.70 | Change | Price | % |
| High | 26.40 | 1 Day | 2.40 | 10.00 |
| Low | 23.70 | 1 Week | 2.45 | 10.23 |
| Close | 26.40 | 1 Month | 3.55 | 15.54 |
| Volume | 1016305 | 1 Year | -2.05 | -7.21 |
| 52 Week High 33.90 | 52 Week Low 21.90 | ||||
TW Taiwan Most Active Stocks
| 2888 | 11.80 | 3.96% |
| 3481 | 23.05 | -6.11% |
| 2303 | 76.20 | 9.96% |
| 2337 | 76.20 | 0.00% |
| 2344 | 115.50 | 2.21% |
| 2367 | 50.10 | 3.30% |
| 2409 | 14.45 | -5.25% |
| 1301 | 51.00 | 4.51% |
| 1326 | 40.55 | 4.11% |
| 1605 | 40.60 | 1.00% |
TW Taiwan Top Gainers Stocks
TW Taiwan Top Losers Stocks
| 4133 Daily Charts |
4133 Intraday Charts |
Whats New @ Bazaartrend |
4133 Free Analysis |
|
|
4133 Important Levels Intraday
| RESISTANCE | 31.60 |
| RESISTANCE | 29.93 |
| RESISTANCE | 28.90 |
| RESISTANCE | 27.87 |
| SUPPORT | 24.93 |
| SUPPORT | 23.90 |
| SUPPORT | 22.87 |
| SUPPORT | 21.20 |
4133 Forecast January 2026
| 4th UP Forecast | 35.75 |
| 3rd UP Forecast | 32.75 |
| 2nd UP Forecast | 30.9 |
| 1st UP Forecast | 29.04 |
| 1st DOWN Forecast | 23.76 |
| 2nd DOWN Forecast | 21.9 |
| 3rd DOWN Forecast | 20.05 |
| 4th DOWN Forecast | 17.05 |
4133 Weekly Forecast
| 4th UP Forecast | 27.65 |
| 3rd UP Forecast | 27.25 |
| 2nd UP Forecast | 27.00 |
| 1st UP Forecast | 26.75 |
| 1st DOWN Forecast | 26.05 |
| 2nd DOWN Forecast | 25.80 |
| 3rd DOWN Forecast | 25.55 |
| 4th DOWN Forecast | 25.15 |
4133 Forecast2026
| 4th UP Forecast | 52.22 |
| 3rd UP Forecast | 43.94 |
| 2nd UP Forecast | 38.82 |
| 1st UP Forecast | 33.7 |
| 1st DOWN Forecast | 19.1 |
| 2nd DOWN Forecast | 13.98 |
| 3rd DOWN Forecast | 8.86 |
| 4th DOWN Forecast | 0.58 |
Abnova (Taiwan) Corporation ( TW Taiwan Symbol : 4133 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4133 Business Profile
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. It offers DNA and RNA, proteins/peptides, SARS-CoV/CoV-2,beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, circulating rare cells, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. The company also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, and IHC/pathology antibodies. In addition, the company's integrated solutions and services include gene synthesis and cytogenetics; peptide, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan. Address: No. 108, Jhouzih Street, Taipei, Taiwan, 114
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service